Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Nuwellis (CHFS) Competitors

Nuwellis logo

CHFS vs. QTI, NRXS, VRAYQ, VIVE, ELMD, SLGL, COEP, WGRX, ATYR, and PRLD

Should you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include QT Imaging (QTI), NeurAxis (NRXS), ViewRay (VRAYQ), Viveve Medical (VIVE), Electromed (ELMD), Sol-Gel Technologies (SLGL), Coeptis Therapeutics (COEP), Wellgistics Health (WGRX), aTyr Pharma (ATYR), and Prelude Therapeutics (PRLD). These companies are all part of the "medical" sector.

Nuwellis vs. Its Competitors

Nuwellis (NASDAQ:CHFS) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, earnings, dividends and profitability.

QT Imaging has a net margin of 0.00% compared to Nuwellis' net margin of -254.26%. QT Imaging's return on equity of 0.00% beat Nuwellis' return on equity.

Company Net Margins Return on Equity Return on Assets
Nuwellis-254.26% -173.61% -131.01%
QT Imaging N/A N/A -65.94%

In the previous week, QT Imaging had 1 more articles in the media than Nuwellis. MarketBeat recorded 1 mentions for QT Imaging and 0 mentions for Nuwellis. QT Imaging's average media sentiment score of 1.61 beat Nuwellis' score of 0.00 indicating that QT Imaging is being referred to more favorably in the news media.

Company Overall Sentiment
Nuwellis Neutral
QT Imaging Very Positive

Nuwellis has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.2, indicating that its share price is 120% less volatile than the S&P 500.

QT Imaging has lower revenue, but higher earnings than Nuwellis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nuwellis$5.51M3.89-$18.11M-$279.28-0.01
QT Imaging$4.00M15.14-$4.03MN/AN/A

65.1% of Nuwellis shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 0.6% of Nuwellis shares are held by company insiders. Comparatively, 75.4% of QT Imaging shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

QT Imaging beats Nuwellis on 8 of the 11 factors compared between the two stocks.

Get Nuwellis News Delivered to You Automatically

Sign up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CHFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CHFS vs. The Competition

MetricNuwellisElectromedical Equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$21.43M$40.95M$6.02B$10.32B
Dividend YieldN/AN/A5.66%4.69%
P/E Ratio-0.073.6285.4226.63
Price / Sales3.89209.57585.24179.51
Price / CashN/A41.3638.3262.20
Price / Book0.282.6512.756.58
Net Income-$18.11M-$2.66M$3.30B$275.87M

Nuwellis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CHFS
Nuwellis
N/A$3.55
-6.1%
N/A+207.3%$21.43M$5.51M-0.0766
QTI
QT Imaging
N/A$2.50
-2.0%
N/A+289.8%$67.84M$4.00M0.00N/APositive News
NRXS
NeurAxis
1.9047 of 5 stars
$3.08
-1.0%
$7.00
+127.3%
+0.7%$30.41M$3.22M-1.6719
VRAYQ
ViewRay
N/AN/AN/AN/A$18K$102.21M0.00300
VIVE
Viveve Medical
N/A$0.00
flat
N/AN/A$2K$6.83M0.0070
ELMD
Electromed
3.7336 of 5 stars
$24.55
+0.0%
$36.25
+47.7%
+15.4%$204.97M$64M32.73160
SLGL
Sol-Gel Technologies
0.6296 of 5 stars
$29.15
+1.4%
N/A+510.0%$80.06M$23.93M-23.7050News Coverage
Analyst Forecast
COEP
Coeptis Therapeutics
1.2917 of 5 stars
$17.46
+5.8%
N/A+354.7%$79.58MN/A-3.012News Coverage
Positive News
Analyst Forecast
WGRX
Wellgistics Health
N/A$0.89
-5.6%
N/AN/A$79.02M$18.13M0.0031Analyst Forecast
ATYR
aTyr Pharma
3.2035 of 5 stars
$0.72
-9.3%
$23.25
+3,122.9%
-54.8%$77.92M$230K-0.9053Trending News
Analyst Forecast
Insider Trade
Gap Up
PRLD
Prelude Therapeutics
3.3137 of 5 stars
$1.44
+5.1%
$4.00
+177.8%
-26.3%$77.54M$7M-0.88120News Coverage
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:CHFS) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners